Skip to content

Seth Klarman portfolio · Q3 2014

The Baupost Group, L.L.C. · CIK 0001061768 ·13F filings on SEC EDGAR

In Q3 2014, The Baupost Group, L.L.C. reported 27 positions worth $5.7B. Its largest holding was MU at 30.8% of the portfolio, and the top 10 made up 85%. Its largest new position was 675746309 ($183.3M), and it sold out of IDIX.

Portfolio value
$5.7B
Positions
27
Top 10 share
85.1%
Changes vs Jun 30, 2014
  • NEW 4
  • ADD 6
  • REDUCE 3
  • EXIT 1

Portfolio map

NEWADDHOLDREDUCE

Each box is a position sized by its value. Color shows the change in shares from the previous quarter.

Portfolio history

Q2 2013 to Q3 2014, 6 quarters

Weight of the largest holdings

The 7 holdings with the highest weight in any quarter shown, stacked with all others to 100%.

MUTHERAVANCE INCIDIXVSATBPLNGAIGOther

Holding timeline

Shade shows the weight in each quarter. A blank cell means the holding was not reported that quarter.

< 1%1–3%3–6%6–10%10–20%20–35%≥ 35%

Holdings

Click a holding to see its price chart with the quarters the investor bought or sold.

NameWeightAvg. cost (est.)Latest priceGain/lossValue
88338TAB0
THERAVANCE INC
PRN
0.29%———$16.4M

Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price. * Held since before Jun 30, 2013, when our collected history starts, so the average starts from that quarter's price.

Changes in shares

Change in shares held vs Jun 30, 2014, for the 14 largest positions that changed. Bars are capped at ±100%; the label shows the actual change.

NEWADDREDUCEEXIT

Sold out this quarter

Held on Jun 30, 2014 and not reported for Q3 2014.

StockPrior weightPrior sharesPrior valueChange
IDIX
IDENIX PHARMACEUTICALS LLC
20.67%53,331,109$1.3BEXIT

SEC filings for Q3 2014